blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3421600

EP3421600 - LIVER-TYPE FATTY ACID-BINDING PROTEIN PREPARATION AND USE THEREOF [Right-click to bookmark this link]
Former [2019/01]LIVER-TYPE FATTY ACID-BINDING PROTEIN PREPARATION, METHOD FOR EVALUATING PREPARATION, METHOD FOR REGULATING VARIATION RANGE OF MEASURED VALUE CAUSED BY LIVER-TYPE FATTY ACID-BINDING PROTEIN IN MEASUREMENT USING PREPARATION, LIVER-TYPE FATTY ACID-BINDING PROTEIN, DNA ENCODING PROTEIN, CELL TRANSFORMED BY DNA, METHOD FOR PRODUCING PROTEIN, METHOD FOR DRAWING CALIBRATION CURVE FOR LIVER-TYPE FATTY ACID-BINDING PROTEIN, AND METHOD FOR QUANTIFYING PROTEIN
[2020/26]
StatusNo opposition filed within time limit
Status updated on  24.09.2021
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  16.10.2020
FormerGrant of patent is intended
Status updated on  15.06.2020
FormerExamination is in progress
Status updated on  16.12.2019
FormerRequest for examination was made
Status updated on  30.11.2018
FormerThe international publication has been made
Status updated on  28.12.2017
Most recent event   Tooltip14.07.2023Lapse of the patent in a contracting state
New state(s): HU
published on 16.08.2023  [2023/33]
Applicant(s)For all designated states
CMIC Holdings Co. Ltd.
1-1-1 Shibaura
Minato-ku
Tokyo 105-0023 / JP
[2019/01]
Inventor(s)01 / SUGAYA, Takeshi
c/o CMIC Holdings Co., Ltd.
1-1-1, Shibaura
Minato-ku
Tokyo 105-0023 / JP
02 / OKAZAKI, Masateru
c/o CMIC Holdings Co., Ltd.
1-1-1, Shibaura
Minato-ku
Tokyo 105-0023 / JP
03 / OIKAWA, Tsuyoshi
c/o CMIC Holdings Co., Ltd.
1-1-1, Shibaura
Minato-ku
Tokyo 105-0023 / JP
 [2019/01]
Representative(s)Appleyard Lees IP LLP
15 Clare Road
Halifax HX1 2HY / GB
[2019/01]
Application number, filing date17813408.615.06.2017
[2019/01]
WO2017JP22209
Priority number, dateJP2016012007316.06.2016         Original published format: JP 2016120073
JP2016024600119.12.2016         Original published format: JP 2016246001
[2019/01]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017217514
Date:21.12.2017
Language:JA
[2017/51]
Type: A1 Application with search report 
No.:EP3421600
Date:02.01.2019
Language:EN
[2019/01]
Type: B1 Patent specification 
No.:EP3421600
Date:18.11.2020
Language:EN
[2020/47]
Search report(s)International search report - published on:JP21.12.2017
(Supplementary) European search report - dispatched on:EP20.02.2019
ClassificationIPC:C12N15/09, C07K14/47, C12N1/15, C12N1/19, C12N1/21, C12N5/10, C12P21/02, G01N33/68
[2019/01]
CPC:
C07K14/47 (EP,US); C12P21/02 (EP); G01N33/68 (EP,US);
G01N2440/00 (EP); G01N2496/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/01]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:LEBERFETTSÄUREBINDENDES PROTEINSPRÄPARAT UND VERFAHREN[2020/26]
English:LIVER-TYPE FATTY ACID-BINDING PROTEIN PREPARATION AND USE THEREOF[2020/26]
French:PRÉPARATION DE PROTÉINE DE LIAISON AUX ACIDES GRAS DU TYPE HÉPATIQUE ET SON UTILISATION[2020/26]
Former [2019/01]PRÄPARAT AUS LEBERFETTSÄUREBINDENDEM PROTEIN, VERFAHREN ZUR BEURTEILUNG DES PRÄPARATS, VERFAHREN ZUR REGELUNG DES VARIATIONSBEREICHS EINES GEMESSENEN WERTS EINES LEBERFETTSÄUREBINDENDEN PROTEINS BEI DER MESSUNG ANHAND DES PRÄPARATS, LEBERFETTSÄUREBINDENDES PROTEIN, DNA-CODIERENDES PROTEIN, DURCH DNA TRANSFORMIERTE ZELLE, VERFAHREN ZUR PROTEINHERSTELLUNG, VERFAHREN ZUR ZEICHNUNG DER KALIBRIERKURVE FÜR LEBERFETTSÄUREBINDENDES PROTEIN UND VERFAHREN ZUR PROTEINQUANTIFIZIERUNG
Former [2019/01]LIVER-TYPE FATTY ACID-BINDING PROTEIN PREPARATION, METHOD FOR EVALUATING PREPARATION, METHOD FOR REGULATING VARIATION RANGE OF MEASURED VALUE CAUSED BY LIVER-TYPE FATTY ACID-BINDING PROTEIN IN MEASUREMENT USING PREPARATION, LIVER-TYPE FATTY ACID-BINDING PROTEIN, DNA ENCODING PROTEIN, CELL TRANSFORMED BY DNA, METHOD FOR PRODUCING PROTEIN, METHOD FOR DRAWING CALIBRATION CURVE FOR LIVER-TYPE FATTY ACID-BINDING PROTEIN, AND METHOD FOR QUANTIFYING PROTEIN
Former [2019/01]PRÉPARATION DE PROTÉINE DE LIAISON AUX ACIDES GRAS DU TYPE HÉPATIQUE, PROCÉDÉ D'ÉVALUATION DE LA PRÉPARATION, PROCÉDÉ DE RÉGULATION DE LA PLAGE DE VARIATION DE LA VALEUR MESURÉE PROVOQUÉE PAR LA PROTÉINE DE LIAISON AUX ACIDES GRAS DU TYPE HÉPATIQUE DANS LA MESURE À L'AIDE DE LA PRÉPARATION, PROTÉINE DE LIAISON AUX ACIDES GRAS DU TYPE HÉPATIQUE, ADN CODANT POUR LA PROTÉINE, CELLULE TRANSFORMÉE PAR L'ADN, PROCÉDÉ DE PRODUCTION DE PROTÉINE, PROCÉDÉ POUR TRACER UNE COURBE D'ÉTALONNAGE D'UNE PROTÉINE DE LIAISON AUX ACIDES GRAS DU TYPE HÉPATIQUE, ET PROCÉDÉ DE QUANTIFICATION DE LA PROTÉINE
Entry into regional phase24.09.2018Translation filed 
24.09.2018National basic fee paid 
24.09.2018Search fee paid 
24.09.2018Designation fee(s) paid 
24.09.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
24.09.2018Examination requested  [2019/01]
05.09.2019Amendment by applicant (claims and/or description)
19.12.2019Despatch of a communication from the examining division (Time limit: M04)
29.04.2020Reply to a communication from the examining division
16.06.2020Communication of intention to grant the patent
12.10.2020Fee for grant paid
12.10.2020Fee for publishing/printing paid
12.10.2020Receipt of the translation of the claim(s)
Opposition(s)19.08.2021No opposition filed within time limit [2021/43]
Fees paidRenewal fee
21.06.2019Renewal fee patent year 03
08.06.2020Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.06.2017
AL18.11.2020
AT18.11.2020
CY18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
IE15.06.2021
LU15.06.2021
BE30.06.2021
[2023/33]
Former [2023/30]AL18.11.2020
AT18.11.2020
CY18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
IE15.06.2021
LU15.06.2021
BE30.06.2021
Former [2022/34]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
IE15.06.2021
LU15.06.2021
BE30.06.2021
Former [2022/23]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
IE15.06.2021
LU15.06.2021
Former [2022/21]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
PT18.03.2021
IE15.06.2021
LU15.06.2021
Former [2022/18]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
PT18.03.2021
LU15.06.2021
Former [2022/10]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
PT18.03.2021
Former [2022/08]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/50]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/45]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/37]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/36]AT18.11.2020
CZ18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/35]AT18.11.2020
CZ18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
PL18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/33]AT18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
PL18.11.2020
RS18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/32]AT18.11.2020
FI18.11.2020
HR18.11.2020
LV18.11.2020
PL18.11.2020
RS18.11.2020
SM18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/28]AT18.11.2020
FI18.11.2020
HR18.11.2020
LV18.11.2020
PL18.11.2020
RS18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/25]AT18.11.2020
FI18.11.2020
LV18.11.2020
PL18.11.2020
RS18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/23]AT18.11.2020
FI18.11.2020
LV18.11.2020
RS18.11.2020
BG18.02.2021
NO18.02.2021
GR19.02.2021
PT18.03.2021
Former [2021/22]FI18.11.2020
RS18.11.2020
NO18.02.2021
PT18.03.2021
Former [2021/21]FI18.11.2020
PT18.03.2021
Former [2021/20]FI18.11.2020
Documents cited:Search[A]  - THOMPSON JAMES ET AL, "The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates", JOURNAL OF BIOLOGICAL CHEMISTRY, (19970314), vol. 272, no. 11, ISSN 0021-9258, pages 7140 - 7150, XP002788455 [A] 7,8 * page 7143; figure 1 * * page 7146; figure 4 *

DOI:   http://dx.doi.org/10.1074/jbc.272.11.7140
 [A]  - "RENISHEM L-FABP ELISA TMB Kit A kit for quantitative determination of human LFABP in urine", (201508), pages 1 - 4, CMIC HOLDING Co., TOKYO, URL: https://www.fabp.jp/eng/pdf/161114_tmb_inst.pdf, (20190128), XP002788456 [A] 1-15 * page 3, column r, paragraph "quality control" * * page 4, column l, paragraph "3. repeatability" *
International search[A]JPH08304395  (BETSUSERU RES LAB KK) [A] 1-15* , example 2 (Family: none) *;
 [A]WO2011007823  (UNIV TOKYO [JP], et al) [A] 1-15 * , example 1 & US 2012/0135433 A1 example 1 *;
 [A]  - Ronald G.H.J. Maatman et al., "Expression of human liver fatty acid-binding protein in Escherichia coli and comparative analysis of its binding characteristics with muscle fatty acid-binding protein", Biochim. Biophys. Acta ., (19940000), vol. 1214, no. 1, pages 1 - 10, XP 023366541 [A] 1-15 * , particularly, summary, page 3, left column, 3rd paragraph to right column, 3rd paragraph, table 1 *
 [A]  - KIM YUN HO et al., "Comparing the effect on protein stability of methionine oxidation versus mutagenesis: Steps toward engineering oxidative resistance in proteins", Protein Engineering, (20010000), vol. 14, no. 5, pages 343 - 347, XP 002251172 [A] 1-15 * , particularly, 'Introduction', 2nd to 4th paragraphs *
 [A]  - Mark Cornell Manning et al., "Stability of Protein Pharmaceuticals: An Update", Pharmaceutical Res ., (20100000), vol. 27, no. 4, pages 544 - 575, XP 019793935 [A] 1-15 * , particularly, page 551, 'Methionine Sanka' *
 [A]  - Jing Yan, "Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity", J. Lipid Res., (20090000), vol. 50, no. 12, pages 2445 - 2454, XP 055465183 [A] 1-15 * , particularly, summary, page 2446, left column, 2nd paragraph, pages 2450 to 2451, 'Sanka Methionine Zanki no Dotei', page 2452, right column, 3rd paragraph to page 2453, left column, 1st paragraph *
 [A]  - "Lenapro L-FABP test TMB", Data sheet, 3rd ed., (20150000), pages 1 - 4, URL: https://www.fabp.jp/pdf/MSDS_L-FABP.pdf, XP009508454 [A] 1-15 * , particularly, 'Keijo*Kozo To', 'Shiyo Mokuteki', 'Sokutei Genri', 'Yoho*Yoryo' *
ExaminationUS2012135433
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.